Patents by Inventor Allergan Sales, LLC

Allergan Sales, LLC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN
    Publication number: 20130203834
    Abstract: Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
    Type: Application
    Filed: March 14, 2013
    Publication date: August 8, 2013
    Applicant: ALLERGAN SALES, LLC
    Inventor: ALLERGAN SALES, LLC
  • KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN
    Publication number: 20130203833
    Abstract: Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
    Type: Application
    Filed: March 14, 2013
    Publication date: August 8, 2013
    Applicant: ALLERGAN SALES, LLC
    Inventor: Allergan Sales, LLC
  • COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE
    Publication number: 20130196995
    Abstract: Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
    Type: Application
    Filed: March 13, 2013
    Publication date: August 1, 2013
    Applicant: ALLERGAN SALES, LLC
    Inventor: Allergan Sales, LLC
  • KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN
    Publication number: 20130197051
    Abstract: Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
    Type: Application
    Filed: March 13, 2013
    Publication date: August 1, 2013
    Applicant: ALLERGAN SALES, LLC
    Inventor: Allergan Sales, LLC